Fecal Serine Protease Profiling in Inflammatory Bowel Diseases.

Holobiont fecal proteases gut microbiota inflammatory bowel diseases microbiome protease profiling serine protease inhibitors

Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2020
Historique:
received: 16 10 2019
accepted: 14 01 2020
entrez: 3 3 2020
pubmed: 3 3 2020
medline: 22 6 2021
Statut: epublish

Résumé

Serine proteases are extensively known to play key roles in many physiological processes. However, their dysregulation is often associated to several diseases including inflammatory bowel diseases (IBD). Here, we used specific substrates to monitor fecal protease activities in a large cohort of healthy and IBD patients. Of interest, serine protease activity was 10-fold higher in IBD fecal samples compared to healthy controls. Moreover, functional analysis of these fecal proteolytic activities revealed that the most increased activities are trypsin-like, elastase-like and cathepsin G-like. We also show for the first time, an increase of proteinase 3-like activity in these samples compared to controls. Results presented here will guide further investigations to better understand the relevance of these peptidases in IBD.

Identifiants

pubmed: 32117798
doi: 10.3389/fcimb.2020.00021
pmc: PMC7011180
doi:

Substances chimiques

Serine Proteases EC 3.4.-
Pancreatic Elastase EC 3.4.21.36

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21

Informations de copyright

Copyright © 2020 Jablaoui, Kriaa, Mkaouar, Akermi, Soussou, Wysocka, Wołoszyn, Amouri, Gargouri, Maguin, Lesner and Rhimi.

Références

Inflamm Bowel Dis. 2014 Dec;20(12):2364-78
pubmed: 25401721
PLoS One. 2013 Jun 20;8(6):e66074
pubmed: 23840402
Bioorg Med Chem Lett. 2006 Jun 1;16(11):2882-5
pubmed: 16554154
Sci Transl Med. 2012 Oct 31;4(158):158ra144
pubmed: 23115353
Sci Rep. 2018 May 18;8(1):7834
pubmed: 29777136
World J Gastroenterol. 2017 Mar 28;23(12):2106-2123
pubmed: 28405139
Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1673-8
pubmed: 22307629
Gut. 2017 Sep;66(9):1573-1583
pubmed: 27216938
Microb Ecol Health Dis. 2015 Feb 02;26:26191
pubmed: 25651997
Scand J Gastroenterol. 2001 Feb;36(2):174-9
pubmed: 11252410
Cell Tissue Res. 2013 Feb;351(2):269-80
pubmed: 22427120
Gut. 2016 Jul;65(7):1215-24
pubmed: 27196587
BMC Gastroenterol. 2012 Jun 24;12:76
pubmed: 22726388
J Immunol. 2004 Jul 1;173(1):428-36
pubmed: 15210802
Chem Rev. 2002 Dec;102(12):4501-24
pubmed: 12475199
Clin Gastroenterol Hepatol. 2007 May;5(5):550-5
pubmed: 17336590
Gut. 2008 May;57(5):591-9
pubmed: 18194983
Am J Pathol. 2002 Nov;161(5):1903-15
pubmed: 12414536
Clin Chim Acta. 2012 Apr 11;413(7-8):719-26
pubmed: 22265712
Nat Rev Gastroenterol Hepatol. 2015 Dec;12(12):720-7
pubmed: 26323879
Gut. 2017 Oct;66(10):1767-1778
pubmed: 28096305
Methods Mol Biol. 2017;1626:53-70
pubmed: 28608200
Am J Pathol. 2009 Jul;175(1):207-14
pubmed: 19528350
Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13780-5
pubmed: 17699621
FEBS Lett. 2003 Jun 5;544(1-3):129-32
pubmed: 12782302
Medicina (B Aires). 1998;58(3):262-4
pubmed: 9713093
Gut. 2007 Jan;56(1):61-72
pubmed: 16822808
Ann Gastroenterol Surg. 2018 Jun 02;2(4):282-288
pubmed: 30003191
Am J Physiol Gastrointest Liver Physiol. 2016 Feb 15;310(4):G234-9
pubmed: 26702140

Auteurs

Amin Jablaoui (A)

Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Microbiota Interaction with Human and Animal Team (MIHA), Jouy-en-Josas, France.

Aicha Kriaa (A)

Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Microbiota Interaction with Human and Animal Team (MIHA), Jouy-en-Josas, France.

Héla Mkaouar (H)

Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Microbiota Interaction with Human and Animal Team (MIHA), Jouy-en-Josas, France.

Nizar Akermi (N)

Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Microbiota Interaction with Human and Animal Team (MIHA), Jouy-en-Josas, France.

Souha Soussou (S)

Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Microbiota Interaction with Human and Animal Team (MIHA), Jouy-en-Josas, France.

Magdalena Wysocka (M)

Faculty of Chemistry, University of Gdansk, Gdansk, Poland.

Dominika Wołoszyn (D)

Faculty of Chemistry, University of Gdansk, Gdansk, Poland.

Ali Amouri (A)

Department of Gastroenterology, Hedi Chaker University Hospital, Sfax, Tunisia.

Ali Gargouri (A)

Laboratory of Molecular Biology of Eukaryotes, Center of Biotechnology of Sfax, University of Sfax, Sfax, Tunisia.

Emmanuelle Maguin (E)

Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Microbiota Interaction with Human and Animal Team (MIHA), Jouy-en-Josas, France.

Adam Lesner (A)

Faculty of Chemistry, University of Gdansk, Gdansk, Poland.

Moez Rhimi (M)

Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Microbiota Interaction with Human and Animal Team (MIHA), Jouy-en-Josas, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH